106 results on '"Puranik R"'
Search Results
2. Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution.
- Author
-
Fairley, JL, O'Rourke, R, Puranik, R, Nikpour, M, Fairley, JL, O'Rourke, R, Puranik, R, and Nikpour, M
- Abstract
Cardiac magnetic resonance imaging (CMR) is the gold-standard non-invasive method of assessing cardiac structure and function, including tissue characterisation. In systemic sclerosis (SSc), heart involvement (SHI) is a leading cause of mortality yet remains poorly understood. SHI is underestimated by conventional echocardiography, and CMR provides an important opportunity to better identify and quantify subtle myocardial changes including oedema and fibrosis. This review summarises current CMR techniques, the role of CMR in SSc and SHI, and the opportunities to further our understanding of its pathogenesis and management.
- Published
- 2024
3. Hibernoma: a case report of a rare cardiac tumour
- Author
-
Cistulli, D, primary, Othman, F, additional, Karim, R, additional, and Puranik, R, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Outcomes of 10 years of cardiac screening of elite New Zealand athletes
- Author
-
Orchard, J, primary, Orchard, J W, additional, Davis, A J, additional, Puranik, R, additional, Isbister, J, additional, La Gerche, A, additional, Driscoll, T, additional, Doughty, R N, additional, and Hamilton, B, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design
- Author
-
Tran, DL, Gibson, H, Maiorana, AJ, Verrall, CE, Baker, DW, Clode, M, Lubans, DR, Zannino, D, Bullock, A, Ferrie, S, Briody, J, Simm, P, Wijesekera, V, D'Almeida, M, Gosbell, SE, Davis, GM, Weintraub, R, Keech, AC, Puranik, R, Ugander, M, Justo, R, Zentner, D, Majumdar, A, Grigg, L, Coombes, JS, d'Udekem, Y, Morris, NR, Ayer, J, Celermajer, DS, Cordina, R, Tran, DL, Gibson, H, Maiorana, AJ, Verrall, CE, Baker, DW, Clode, M, Lubans, DR, Zannino, D, Bullock, A, Ferrie, S, Briody, J, Simm, P, Wijesekera, V, D'Almeida, M, Gosbell, SE, Davis, GM, Weintraub, R, Keech, AC, Puranik, R, Ugander, M, Justo, R, Zentner, D, Majumdar, A, Grigg, L, Coombes, JS, d'Udekem, Y, Morris, NR, Ayer, J, Celermajer, DS, and Cordina, R
- Abstract
Background: Despite developments in surgical techniques and medical care, people with a Fontan circulation still experience long-term complications; non-invasive therapies to optimize the circulation have not been established. Exercise intolerance affects the majority of the population and is associated with worse prognosis. Historically, people living with a Fontan circulation were advised to avoid physical activity, but a small number of heterogenous, predominantly uncontrolled studies have shown that exercise training is safe-and for unique reasons, may even be of heightened importance in the setting of Fontan physiology. The mechanisms underlying improvements in aerobic exercise capacity and the effects of exercise training on circulatory and end-organ function remain incompletely understood. Furthermore, the optimal methods of exercise prescription are poorly characterized. This highlights the need for large, well-designed, multi-center, randomized, controlled trials. Aims and Methods: The Fontan Fitness Intervention Trial (F-FIT)-a phase III clinical trial-aims to optimize exercise prescription and delivery in people with a Fontan circulation. In this multi-center, randomized, controlled study, eligible Fontan participants will be randomized to either a 4-month supervised aerobic and resistance exercise training program of moderate-to-vigorous intensity followed by an 8-month maintenance phase; or usual care (control group). Adolescent and adult (≥16 years) Fontan participants will be randomized to either traditional face-to-face exercise training, telehealth exercise training, or usual care in a three-arm trial with an allocation of 2:2:1 (traditional:telehealth:control). Children (<16 years) will be randomized to either a physical activity and exercise program of moderate-to-vigorous intensity or usual care in a two-arm trial with a 1:1 allocation. The primary outcome is a change in aerobic exercise capacity (peak oxygen uptake) at 4-months. Secondary outcom
- Published
- 2022
6. Oral Cysticercosis: A Case Report and Review of Literature
- Author
-
Hosur, Mahadevi B., Byakodi, Sanjay, Puranik, R. S., Vanaki, Shreenivas S., Puranik, Surekha R., and Shivakumar, M. S.
- Published
- 2015
- Full Text
- View/download PDF
7. A perspective of the interlamellar region of organo-clays by adsorption of aromatic hydrocarbons
- Author
-
Vijayalakshmi Puranik, R., Kumar, Prakash, Bhat, Y. S., and Jai Prakash, B. S.
- Published
- 2010
- Full Text
- View/download PDF
8. Schwannoma of Parapharyngeal Space
- Author
-
Giraddi, Girish, Vanaki, Shrinivas S., and Puranik, R. S.
- Published
- 2010
- Full Text
- View/download PDF
9. Elastic Chest Compression Reduced Hyperinflation in People with Chronic Obstructive Pulmonary Disease
- Author
-
Chapman, DG, Arnott, C, Puranik, R, Prael, G, Patel, K, Tonga, KO, Milne, S, Zimmermann, SC, Munoz, PA, Lake, CD, Kaminsky, DA, Lau, E, King, GG, Chapman, DG, Arnott, C, Puranik, R, Prael, G, Patel, K, Tonga, KO, Milne, S, Zimmermann, SC, Munoz, PA, Lake, CD, Kaminsky, DA, Lau, E, and King, GG
- Published
- 2020
10. Challenges in Diagnosis of Mesenchymal Chondrosarcoma “The Importance of Histopathologic Analysis”.
- Author
-
Goudar, Archana, Puranik, R. S., Puranik, S. R., Ramesh, Saahil, and Yog Naag Amaran, E. G.
- Subjects
SURGICAL margin ,LITERATURE reviews ,ALVEOLAR process ,BENIGN tumors ,ORAL radiography - Abstract
This article discusses the challenges in diagnosing mesenchymal chondrosarcoma, a rare and aggressive tumor that can mimic benign oral growths. The case report presented in the article describes a 34-year-old male patient with a mass in the mandibular anterior region. The tumor was initially thought to be benign due to its clinical appearance, but histopathologic analysis confirmed it to be mesenchymal chondrosarcoma. The article emphasizes the importance of thorough evaluation and surgical excision with negative margins for successful treatment. [Extracted from the article]
- Published
- 2024
11. Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity
- Author
-
Jonge, M.M. de, Ritterhouse, L.L., Kroon, C.D. de, Vreeswijk, M.P.G., Segal, J.P., Puranik, R., Rookus, M.A., Hogervorst, F.B.L., Leeuwen, F.E. van, Adank, M.A., Schmidt, M.K., Jenner, D.J., Collee, J.M., Ouweland, A.M.W. van den, Hooning, M.J., Boere, I.A., Asperen, C.J. van, Devilee, P., Luijt, R.B. van der, Cronenburg, T.C.T.E.F. van, Wevers, M.R., Mensenkamp, A.R., Ausems, M.G.E.M., Koudijs, M.J., Meijers-Heijboer, H.E.J., Os, T.A.M. van, Engelen, K. van, Gille, J.J.P., Gomez-Garcia, E.B., Blok, M.J., Boer, M. de, Oosterwijk, J.C., Hout, A.H. van der, Mourits, M.J., Bock, G.H. de, Siesling, S., Verloop, J., Broek, E.C. van den, Hollema, H., Smit, V.T.H.B.M., Howitt, B.E., Bosse, T., HEBON Grp, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Life Course Epidemiology (LCE), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Klinische Genetica, MUMC+: DA KG Polikliniek (9), RS: GROW - R4 - Reproductive and Perinatal Medicine, MUMC+: DA KG Lab Centraal Lab (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Promovendi ODB, Clinical Genetics, and Medical Oncology
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,MAINTENANCE THERAPY ,TAMOXIFEN TREATMENT ,PROGNOSIS ,Germline ,Loss of heterozygosity ,03 medical and health sciences ,0302 clinical medicine ,Germline mutation ,All institutes and research themes of the Radboud University Medical Center ,Internal medicine ,medicine ,Carcinoma ,BREAST-CANCER ,RISK ,Women's cancers Radboud Institute for Molecular Life Sciences [Radboudumc 17] ,business.industry ,MUTATIONS ,Endometrial cancer ,WOMEN ,Histology ,medicine.disease ,OVARIAN ,UTERINE SEROUS CARCINOMA ,030104 developmental biology ,030220 oncology & carcinogenesis ,CLEAR-CELL ,Ovarian cancer ,business ,Cohort study ,Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] - Abstract
Purpose: Whether endometrial carcinoma (EC) should be considered part of the gBRCA1/2-associated hereditary breast and ovarian cancer (HBOC) syndrome is topic of debate. We sought to assess whether ECs occurring in gBRCA carriers are enriched for clinicopathologic and molecular characteristics, thereby supporting a causal relationship. Experimental Design: Thirty-eight gBRCA carriers that developed EC were selected from the nationwide cohort study on hereditary breast and ovarian cancer in the Netherlands (HEBON), and these were supplemented with four institutional cases. Tumor tissue was retrieved via PALGA (Dutch Pathology Registry). Nineteen morphologic features were scored and histotype was determined by three expert gynecologic pathologists, blinded for molecular analyses (UCM-OncoPlus Assay including 1213 genes). ECs with LOH of the gBRCA-wild-type allele (gBRCA/LOHpos) were defined “gBRCA-associated,” those without LOH (gBRCA/LOHneg) were defined “sporadic.” Results: LOH could be assessed for 40 ECs (30 gBRCA1, 10 gBRCA2), of which 60% were gBRCA/LOHpos. gBRCA/LOHpos ECs were more frequently of nonendometrioid (58%, P = 0.001) and grade 3 histology (79%, P < 0.001). All but two were in the TP53-mutated TCGA-subgroup (91.7%, P < 0.001). In contrast, gBRCA/LOHneg ECs were mainly grade 1 endometrioid EC (94%) and showed a more heterogeneous distribution of TCGA-molecular subgroups: POLE-mutated (6.3%), MSI-high (25%), NSMP (62.5%), and TP53-mutated (6.3%). Conclusions: We provide novel evidence in favor of EC being part of the gBRCA-associated HBOC-syndrome. gBRCA-associated ECs are enriched for EC subtypes associated with unfavorable clinical outcome. These findings have profound therapeutic consequences as these patients may benefit from treatment strategies such as PARP inhibitors. In addition, it should influence counseling and surveillance of gBRCA carriers.
- Published
- 2019
12. DENTIGEROUS CYST vs. ERUPTION CYST
- Author
-
PURANIK, R S and VANAKI, S S
- Published
- 2007
13. Primary melanoma of oral mucosa: A case report and review of literature
- Author
-
Bhullar, Raman Preet Kaur, Bhullar, Amandeep, Vanaki, Srinivas S., Puranik, R. S., Sudhakara, M., and Kamat, Mamata S.
- Subjects
lcsh:RK1-715 ,stomatognathic diseases ,recurrence ,lcsh:Dentistry ,Gingiva ,metastasis ,Case Report ,oral melanoma - Abstract
Primary oral melanoma is a rare neoplasm of melanocytic origin, accounting for 0.5% of all oral malignancies. The “chameleonic” presentation of a mainly asymptomatic condition, rarity of this lesion, poor prognosis, and the necessity of a highly specialized treatment are factors that should be seriously considered by the involved health provider. Here is a case report presenting a malignant melanoma of oral mucosa in 48-year-old male patient on maxillary gingiva. The lesion was removed by partial maxillectomy and patient is disease free after 11 months of regular followup. This case provides an example of how dental clinicians play a major role in the identification of pigmented lesions of oral cavity and also emphasize on the fact that any pigmented lesion detected in the oral cavity may exhibit potential growth and should be submitted to biopsy to exclude malignancy.
- Published
- 2012
14. 1216Non-invasive multimodality assessment in brugada Syndrome: insights into pathogenic basis and risk stratification
- Author
-
Gray, B., primary, Gnanappa, G.K., additional, Bagnall, R.D., additional, Yeates, L.M., additional, Ingles, J., additional, Burns, C., additional, Puranik, R., additional, Grieve, S.M., additional, Semsarian, C., additional, and Sy, R.W., additional
- Published
- 2017
- Full Text
- View/download PDF
15. FOSSIL SPORES RAMANUJAMOSPORITES MOHGAOENSE GEN. NOV. SP. NOV. FROM MOHGAONKALAN INTERTRAPPEAN BEDS OF INDIA
- Author
-
ijrbat and S. G. Lanjewar, S. D. Puranik, R. S. Sakundarwar
- Subjects
Botany ,Intertrappean Beds ,Geology ,Spore - Published
- 2015
- Full Text
- View/download PDF
16. Comparison of conventional autopsy and magnetic resonance imaging in determining the cause of sudden death in the young
- Author
-
Puranik, R, Gray, B, Lackey, H, Yeates, L, Parker, G, Duflou, J, Semsarian, C, Puranik, R, Gray, B, Lackey, H, Yeates, L, Parker, G, Duflou, J, and Semsarian, C
- Abstract
Background: Sudden death in the young is a tragic complication of a number of medical diseases. There is limited data regarding the utility of post-mortem Magnetic Resonance (MR) imaging and Computer Tomography (CT) scanning in determining the cause of sudden death. This study sought to compare the accuracy of post-mortem cross-sectional imaging (MR and CT) with the conventional autopsy in determining the cause of sudden death in the young. Methods. Consecutive patients from 2010 to 2012 (aged 1-35 years) who had sudden death were included. Patients were scanned by CT and 1.5 T MR imaging prior to the conventional autopsy being performed. The primary outcome was diagnostic congruence between imaging and conventional autopsy. Results: In 17 patients studied, the mean age at death was 23 ± 11 years, with a male predominance (n = 12; 71%). The most common cause of death was a primary cardiac pathology (n = 8; 47%), including ARVC (24%) and ischemic heart disease (12%). Non-cardiac causes identified included pulmonary embolism (6%), and aortic dissection (6%). MR imaging correctly identified the diagnosis in 12 patients who subsequently had positive findings at conventional autopsy, while the diagnosis in the remaining 5 cases remained unexplained. MR imaging was found to be highly sensitive (100%) with a high negative (100%) and positive (80%) predictive value. Conclusions: Dedicated post-mortem MR imaging of the heart and brain is a useful modality in determining the cause of sudden death in children and young adults, particularly in situations where a conventional autopsy cannot be performed for logistic, cultural or personal reasons. © 2014 Puranik et al.; licensee BioMed Central Ltd.
- Published
- 2014
17. Role of 3β-hydroxysteroid-Δ24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells
- Author
-
McGrath, KCY, Li, XH, Puranik, R, Liong, EC, Tan, JTM, Dy, VM, Dibartolo, BA, Barter, PJ, Rye, KA, and Heather, AK
- Subjects
Oxidoreductases Acting on CH-CH Group Donors ,Vascular Cell Adhesion Molecule-1 ,Nerve Tissue Proteins ,Transfection ,Cholesterol, Dietary ,NF-KappaB Inhibitor alpha ,Animals ,Humans ,RNA, Small Interfering ,Infusions, Intravenous ,Promoter Regions, Genetic ,Cells, Cultured ,Arteritis ,Apolipoprotein A-I ,Tumor Necrosis Factor-alpha ,Gene Expression Profiling ,NF-kappa B ,Endothelial Cells ,Atherosclerosis ,I-kappa B Kinase ,Disease Models, Animal ,Cardiovascular System & Hematology ,Gene Expression Regulation ,RNA Interference ,I-kappa B Proteins ,Rabbits ,Lipoproteins, HDL - Abstract
OBJECTIVE-: The purpose of this study was to investigate the ability of high-density lipoproteins (HDLs) to upregulate genes with the potential to protect against inflammation in endothelial cells. METHODS AND RESULTS-: Human coronary artery endothelial cells (HCAECs) were exposed to reconstituted HDLs (rHDLs) for 16 hours before being activated with tumor necrosis factor-α (TNF-α) for 5 hours. rHDLs decreased vascular cell adhesion molecule-1 (VCAM-1) promoter activity by 75% (P
- Published
- 2009
18. These abstracts have been selected for VIEWING only as ePosters and in print. ePosters will be available on Screen A & B throughout the meeting, Print Posters at the times indicated below. Please refer to the PROGRAM for more details.
- Author
-
Secchi, F., primary, Cannao, P., additional, Pluchinotta, F., additional, Butera, G., additional, Carminati, M., additional, Sardanelli, F., additional, Lombardi, M., additional, Monney, P., additional, Piccini, D., additional, Rutz, T., additional, Vincenti, G., additional, Coppo, S., additional, Koestner, S., additional, Stuber, M., additional, Schwitter, J., additional, Romana, P., additional, Francesco, S., additional, Gianfranco, B., additional, Mario, C., additional, Massimo, L., additional, Alizadeh Sani, Z., additional, Vojdan-Parast, M., additional, Alimohammadi, M., additional, Sarafan-Sadeghi, S., additional, Seifi, A., additional, Fallahabadi, H., additional, Karami Tanha, F., additional, Jamshidi, M., additional, Hesamy, M., additional, Bonello, B., additional, Sorensen, C., additional, Fouilloux, V., additional, Gorincour, G., additional, Mace, L., additional, Fraisse, A., additional, Jacquier, A., additional, de Meester, C., additional, Amzulescu, M., additional, Bouzin, C., additional, Boileau, L., additional, Melchior, J., additional, Boulif, J., additional, Lazam, S., additional, Pasquet, A., additional, Vancrayenest, D., additional, Vanoverschelde, J., additional, Gerber, B., additional, Loudon, M., additional, Bull, S., additional, Bissell, M., additional, Joseph, J., additional, Neubauer, S., additional, Myerson, S., additional, Dorniak, K., additional, Hellmann, M., additional, Rawicz-Zegrzda, D., additional, W sierska, M., additional, Sabisz, A., additional, Szurowska, E., additional, Heiberg, E., additional, Dudziak, M., additional, Kwok, T., additional, Chin, C., additional, Dweck, M., additional, Hadamitzky, M., additional, Nadjiri, J., additional, Hendrich, E., additional, Pankalla, C., additional, Will, A., additional, Schunkert, H., additional, Martinoff, S., additional, Sonne, C., additional, Pepe, A., additional, Meloni, A., additional, Terrazzino, F., additional, Spasiano, A., additional, Filosa, A., additional, Bitti, P., additional, Tangari, C., additional, Restaino, G., additional, Resta, M., additional, Ricchi, P., additional, Tudisca, C., additional, Grassedonio, E., additional, Positano, V., additional, Piraino, B., additional, Romano, N., additional, Keilberg, P., additional, Midiri, M., additional, Macchi, S., additional, Ambrosio, D., additional, De Marchi, D., additional, Chiodi, E., additional, Salvatori, C., additional, Artang, R., additional, Bogachkov, A., additional, Botelho, M., additional, Bou-Ayache, J., additional, Vazquez, M., additional, Carr, J., additional, Collins, J., additional, Maret, E., additional, Ahlander, B., additional, Bjorklund, P., additional, Engvall, J., additional, Cimermancic, R., additional, Inage, A., additional, Mizuno, N., additional, Santarelli, M., additional, Izzi, G., additional, Maddaloni, D., additional, Landini, L., additional, Carulli, G., additional, Oliva, E., additional, Arcioni, F., additional, Fraticelli, V., additional, Toia, P., additional, Renne, S., additional, Rizzo, M., additional, Reinstadler, S., additional, Klug, G., additional, Feistritzer, H., additional, Aschauer, A., additional, Schocke, M., additional, Franz, W., additional, Metzler, B., additional, Melonil, A., additional, Positanol, V., additional, Roccamo, G., additional, Argento, C., additional, Benni, M., additional, De Marchil, D., additional, Missere, M., additional, Prezios, P., additional, Salvatoril, C., additional, Pepel, A., additional, Rossi, G., additional, Cirotto, C., additional, Filati, G., additional, Preziosi, P., additional, Mongeon, F., additional, Fischer, K., additional, Teixeira, T., additional, Friedrich, M., additional, Marcotte, F., additional, Zenge, M., additional, Schmidt, M., additional, Nadar, M., additional, Chevre, P., additional, Rohner, C., additional, Mouratoglou, S., additional, Kallifatidis, A., additional, Giannakoulas, G., additional, Grapsa, J., additional, Kamperidis, V., additional, Pitsiou, G., additional, Stanopoulos, I., additional, Hadjimiltiades, S., additional, Karvounis, H., additional, Ahmed, N., additional, Lawton, C., additional, Ghosh Dastidar, A., additional, Frontera, A., additional, Jackson, A., additional, Cripps, T., additional, Diab, I., additional, Duncan, E., additional, Thomas, G., additional, Bucciarelli-Ducci, C., additional, Kannoly, S., additional, Gosling, O., additional, Ninan, T., additional, Fulford, J., additional, Dalrymple-Haym, M., additional, Shore, A., additional, Bellenger, N., additional, Alegret, J., additional, Beltran, R., additional, Martin, M., additional, Mendoza, M., additional, Elisabetta, C., additional, Teresa, C., additional, Zairo, F., additional, Marcello, N., additional, Clorinda, M., additional, Bruna, M., additional, Vincenzo, P., additional, Alessia, P., additional, Giorgio, B., additional, Mair, J., additional, Kremser, C., additional, Aschauer, S., additional, Tufaro, C., additional, Kammerlander, A., additional, Pfaffenberger, S., additional, Marzluf, B., additional, Bonderman, D., additional, Mascherbauer, J., additional, Kliegel, A., additional, Sailer, A., additional, Brustbauer, R., additional, Sedivy, R., additional, Mayr, H., additional, Manessi, M., additional, Castelvecchio, S., additional, Votta, E., additional, Stevanella, M., additional, Menicanti, L., additional, Secchi, F., additional, Redaelli, A., additional, Reiter, U., additional, Reiter, G., additional, Kovacs, G., additional, Greiser, A., additional, Olschewski, H., additional, Fuchsjager, M., additional, Babayev, J., additional, Mlynarski, R., additional, Mlynarska, A., additional, Sosnowski, M., additional, Pontone, G., additional, Bertella, E., additional, Petulla, M., additional, Russo, E., additional, Innocenti, E., additional, Baggiano, A., additional, Mushtaq, S., additional, Gripari, P., additional, Andreini, D., additional, Tondo, C., additional, Nyktari, E., additional, Izgi, C., additional, Haidar, S., additional, Wage, R., additional, Keegan, J., additional, Wong, T., additional, Mohiaddin, R., additional, Durante, A., additional, Rimoldi, O., additional, Laforgia, P., additional, Gianni, U., additional, Benedetti, G., additional, Cava, M., additional, Damascelli, A., additional, Laricchia, A., additional, Ancona, M., additional, Aurelio, A., additional, Pizzetti, G., additional, Esposito, A., additional, Margonato, A., additional, Colombo, A., additional, De Cobelli, F., additional, Camici, P., additional, Zvaigzne, L., additional, Sergejenko, S., additional, Kal js, O., additional, Ripley, D., additional, Swarbrick, D., additional, Hossain, E., additional, Chawner, R., additional, Moore, J., additional, Aquaro, G., additional, Barison, A., additional, Masci, P., additional, Todiere, G., additional, Strata, E., additional, Di Bella, G., additional, Monasterio, F., additional, Levelt, E., additional, Mahmod, M., additional, Ntusi, N., additional, Ariga, R., additional, Upton, R., additional, Piechnick, S., additional, Francis, J., additional, Schneider, J., additional, Stoll, V., additional, Davis, A., additional, Karamitsos, T., additional, Leeson, P., additional, Holloway, C., additional, Clarke, K., additional, Karwat, K., additional, Tomala, M., additional, Miszalski-Jamka, K., additional, Mrozi ska, S., additional, Kowalczyk, M., additional, Mazur, W., additional, Kereiakes, D., additional, Nessler, J., additional, Zmudka, K., additional, Ja wiec, P., additional, Miszalski-Jamka, T., additional, Ben Yaacoub-Kzadri, I., additional, Harguem, S., additional, Bennaceur, R., additional, Ganzoui, I., additional, Ben Miled, A., additional, Mnif, N., additional, Rodriguez Palomares, J., additional, Ortiz, J., additional, Tejedor, P., additional, Lee, D., additional, Wu, E., additional, Bonow, R., additional, Khanji, M., additional, Castiello, T., additional, Westwood, M., additional, Petersen, S., additional, Storti, S., additional, Quota, A., additional, Smacchia, M., additional, Paci, C., additional, Vallone, A., additional, Valeri, G., additional, keilberg, P., additional, Gargani, L., additional, Guiducci, S., additional, Pugliese, N., additional, Pingitore, A., additional, Cole, B., additional, Douglas, H., additional, Rodden, S., additional, Horan, P., additional, Harbinson, M., additional, Johnston, N., additional, Dixon, L., additional, Choudhary, P., additional, Hsu, C., additional, Grieve, S., additional, Semsarian, C., additional, Richmond, D., additional, Celermajer, D., additional, Puranik, R., additional, Hinojar Baydes, R., additional, Varma, N., additional, Goodman, B., additional, Khan, S., additional, Arroyo Ucar, E., additional, Dabir, D., additional, Schaeffter, T., additional, Nagel, E., additional, Puntmann, V., additional, Hinojar, R., additional, Ucar, E., additional, Ngah, N., additional, Kuo, N., additional, D'Cruz, D., additional, Gaddum, N., additional, Foote, L., additional, Schnackenburg, B., additional, Higgins, D., additional, Nucifora, G., additional, Muser, D., additional, Morocutti, G., additional, Gianfagna, P., additional, Zanuttini, D., additional, Piccoli, G., additional, Proclemer, A., additional, Prati, G., additional, Vitrella, G., additional, Allocca, G., additional, Buttignoni, S., additional, Delise, P., additional, Sinagra, G., additional, Silva, G., additional, Almeida, A., additional, David, C., additional, Francisco, A., additional, Magalhaes, A., additional, Placido, R., additional, Menezes, M., additional, Guimaraes, T., additional, Mendes, A., additional, Nunes Diogo, A., additional, Aneq, M., additional, Papavassiliu, T., additional, Sandberg, R., additional, Schimpf, R., additional, Schoenberg, S., additional, Borggrefe, M., additional, Doesch, C., additional, Tamin, S., additional, Tan, L., additional, Joshi, S., additional, Memon, S., additional, Tangcharoen, T., additional, Prasertkulchai, W., additional, Yamwong, S., additional, Sritara, P., additional, Binti Ngah, N., additional, Cruz, D., additional, Rebellato, L., additional, Daleffe, E., additional, Facchin, D., additional, Melao, F., additional, Paiva, M., additional, Pinho, T., additional, Martins, E., additional, Vasconcelos, M., additional, Madureira, A., additional, Macedo, F., additional, Ramos, I., additional, Maciel, M., additional, Agoston-Coldea, L., additional, Marjanovic, Z., additional, Hadj Khelifa, S., additional, Kachenoura, N., additional, Lupu, S., additional, Soulat, G., additional, Farge-Bancel, D., additional, Mousseaux, E., additional, Dastidar, A., additional, Augustine, D., additional, McAlindon, E., additional, Leite, S., additional, Sousa, C., additional, Rangel, I., additional, El ghannudi, S., additional, Lefoulon, A., additional, Noel, E., additional, Germain, P., additional, Doutreleau, S., additional, Jeung, M., additional, Gangi, A., additional, Roy, C., additional, Pisciella, L., additional, Zachara, E., additional, Federica, R., additional, Emdin, M., additional, Baydes, R., additional, Mahmoud, I., additional, and Jackson, T., additional
- Published
- 2014
- Full Text
- View/download PDF
19. ISOLATED FRACTURE OF THE TROCHLEA: REPORT OF TWO CASES WITH REVIEW OF THE LITERATURE ON THE MECHANISM OF INJURY
- Author
-
Dhurve, Kunal, primary, Patil, Vishal S, additional, A.S, Chandanwale, additional, and Puranik, R G, additional
- Published
- 2013
- Full Text
- View/download PDF
20. Intraluminal mass of the ascending aorta
- Author
-
Ramponi, F., primary, Puranik, R., additional, Wilson, M. K., additional, and Bannon, P. G., additional
- Published
- 2012
- Full Text
- View/download PDF
21. A perspective of the interlamellar region of organo-clays by adsorption of aromatic hydrocarbons
- Author
-
Vijayalakshmi Puranik, R., primary, Kumar, Prakash, additional, Bhat, Y. S., additional, and Jai Prakash, B. S., additional
- Published
- 2009
- Full Text
- View/download PDF
22. Role of 3β-Hydroxysteroid-Δ24 Reductase in Mediating Antiinflammatory Effects of High-Density Lipoproteins in Endothelial Cells
- Author
-
McGrath, K.C.Y., primary, Li, X.H., additional, Puranik, R., additional, Liong, E.C., additional, Tan, J.T.M., additional, Dy, V.M., additional, DiBartolo, B.A., additional, Barter, P.J., additional, Rye, K.A., additional, and Heather, A.K., additional
- Published
- 2009
- Full Text
- View/download PDF
23. Characterization, Localization and Patterning of Lymphatics and Blood Vessels in Oral Squamous Cell Carcinoma: A Comparative Study Using D2-40 and CD-34 IHC Marker.
- Author
-
AGARWAL, DESHANT, PARDHE, NILESH, BAJPAI, MANAS, GUPTA, SHAILENDRA, MATHUR, NIKUNJ, VANAKI, S. S., PURANIK, R. S., and MITTAL, MANOJ
- Subjects
LYMPHATICS ,BLOOD vessels ,SQUAMOUS cell carcinoma ,BIOMARKERS ,CARCINOGENESIS - Abstract
Objectives: Lymphatic metastasis has always been regarded as a major prognostic indicator for disease progression and as a guide for therapeutic strategies to oral squamous cell carcinoma (OSCC). Differentiating lymphatic vessels from blood vessels is difficult, partly due to lack of specific method for identifying lymphatics. A new lymphatic vessel reactive antibody D2-40 has been introduced recently. Here we examined immunohistochemical localization of lymphatic vessels and blood vessels using D2-40 and CD-34 respectively in different histological grades of OSCC. Their expression in intra-tumoural and peri-tumoural region was also compared. Materials and Methods: Forty two formalin-fixed paraffin-embedded tissue blocks of excised specimens of OSCC were immunohistochemically evaluated using D2-40 and CD-34 antibodies. Lymphatic vessel density (LVD) (D2-40 positivity) and micro vessel density (MVD) (CD34 positivity) in both intratumoural and peritumoural areas were assessed by hot spot method. Results: Regardless of histopathological differentiation, LVD and MVD in peritumoural areas were found greater than intratumoural areas (p>0.05). Interestingly, other than lymphatic vessels, D2-40 positivity was also detected in tumour cells as well as in basal layer of epithelium adjacent to OSCC. Two patterns of distribution of CD34 positive vessel - circumscribing type and penetrating type were also observed in the cancer nest area. Conclusion: D2-40 can be used as a marker to differentiate lymphatic vessels from blood vessels. Lymphatic and blood vessel proliferation might be much more extensive in the peritumoural area. D2-40 expression in epithelium adjacent to tumour indicates its role in the process of differentiation. Further, its expression in potential malignant disorder may provide better insight in predicting prognosis and pathogenesis of these lesions. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
24. Comparative evaluation of immunohistochemistry, histopathology and conventional radiography in differentiating periapical lesions.
- Author
-
Saraf, Prahlad A., Kamat, Sharad, Puranik, R. S., Puranik, Surekha, Saraf, Suma P., and Singh, Bhanu Pratap
- Subjects
IMMUNOHISTOCHEMISTRY ,HISTOPATHOLOGY ,DENTAL radiography ,PERIAPICAL granuloma ,ENDODONTICS - Abstract
Background and Aim: Periapical lesions often present differently on the radiograph resulting in a dilemma in the mind of the dentist to arrive at a final diagnosis. Although, histopathologic diagnosis has been used for confirmation of the true nature of periapical lesion, the concept of transformation of periapical granulomas containing epithelium without cystification into cyst remains controversial. The aim of this in vivo study was to evaluate the efficacy of conventional radiography and histopathology in differentiating periapical lesions in adjunct with immunohistochemical analysis. Materials and Method: Thirty patients having large periapical radiolucency that do not heal successfully with routine endodontic therapy in relation to either maxillary or mandibular anterior teeth were selected for the study. Intraoral periapical radiographs were obtained and provisional diagnosis of the apical areas were made. Endodontic surgery was performed to enable histopathogical investigation. The histopathological interpretation was done to arrive at a final diagnosis and selected questionable granulomas were subjected for cytokeratin (CK-14) stain. Results: The histopathological profile of lesions consisted of 66.66% periapical granulomas, 10% cysts, 6.67% abscess and 16.67% granulomas with cystic potential. The radiographic and histopathologic correlation was found in only 30% of these cases. Strong CK-14 expression was observed in all five cases of periapical granuloma with cystic potential. Conclusion: The radiographic diagnosis of periapical lesions remains inconclusive. Although histopathologic examination of periapical lesions gives true nature, the precise nature of subsets of periapical granulomas may be achieved with adjunct use of immunohistochemical markers [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. A perspective of the interlamellar region of organo-clays by adsorption of aromatic hydrocarbons.
- Author
-
Puranik, R. Vijayalakshmi, Kumar, Prakash, Bhat, Y. S., and Prakash, B. S. Jai
- Abstract
Adsorption of aromatic hydrocarbons has been investigated on montmorillonite with and without surfactant modification. The enhanced space created in the surfactant modified organo-clay using quaternary ammonium species increased the amount of adsorption of aromatics depending on the size of the alkyl group attached to benzene ring. The diffusivity values calculated, indicate that diffusivity of all the aromatics studied decreased in the organo-clay. The extent of interlayer space available in the modified clay is compared with that in zeolites having different pore dimensions. A bulky molecule like nitron, though enhanced the interlayer distance, simultaneously blocked the access to newly created space in the hexadecyl trimethyl ammonium (HDTMA)-modified clay. Thus the increase in the interlamellar distance may not reveal the effective interlamellar space but depends on the type of quaternary species used. The available interlamellar space in the modified clay is best studied by adsorbing hydrocarbons of different dimensions. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
26. Erythropoietin doubles the incidence of microvascular obstruction in primary PCI - a randomized controlled trial in acute MI using CMR primary endpoints
- Author
-
Puranik Raj, Taylor Andrew M, Muthurangu Vivek, Moon James C, Boston-Griffiths Edney, Babu Girish, Hasleton Jonathan M, Ludman Andrew J, Yellon Derek M, and Hausenloy Derek J
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2010
- Full Text
- View/download PDF
27. Late enhancement findings in a prospective study concerning late functional outcomes following a Ross Procedure
- Author
-
Bonhoeffer Philip, Cullen Shay, Walker Fiona, Derrick Graham, Lurz Philip, Nordmeyer Johannes, Muthurangu Vivek, Tsang Victor, Norman Wendy, Puranik Raj, Jones Rod, and Taylor Andrew M
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2009
- Full Text
- View/download PDF
28. Artifacts in immunohistochemistry; make out and take out.
- Author
-
Suhagiya, Pankaj, Puranik, R. S., Vanaki, Shreenivas S., and Hosur, Mahadevi B.
- Subjects
IMMUNOHISTOCHEMISTRY ,HISTOPATHOLOGY ,SURGICAL pathology - Abstract
Occurrence of artifacts in routine histopathological and biochemical procedures is expected to happen. Even immunohistochemical procedure is not an exception. In face of availability of literature in regard to artifacts in conventional histopathology, there is dearth of information in regard to the same in immunohistochemistry (IHC). Artifacts though observed post-analytically at interpretation stage, can occur at both pre-analytical and post-analytical stages. These can befall starting from fixation to end stage of addition of chromogen. The recognition and acquainting with regular pattern of staining so as to differentiate true positive staining versus false positive staining and the frequent problem of background staining may have greater impact on the final surgical pathology diagnosis. This poster presents the commonly observed artifacts at various levels of IHC procedures. Recognition and corrections of the same will have impact on the treatment of disease. This necessitates the neophyte pathologist to be familiar with such artifacts while employing IHC as a diagnostic tool. Know, aware and recognize. [ABSTRACT FROM AUTHOR]
- Published
- 2014
29. The profile of red cell distribution width and some hematological parameters in patients of oral submucous fibrosis.
- Author
-
Anuraag A. S., Puranik R. S., Shreenivas S. V., Shivakumar M. S., and Mahadevi B.
- Subjects
ERYTHROCYTES ,IRON in the body ,FIBROSIS - Abstract
Background: Nutritional deficiencies primarily of iron and vitamins are implicated in etiology of oral submucous fibrosis (OSMF). The clinical manifestations of OSMF in due course of disease compel patients to manipulate dietary habits or decrease the intake of conventional diet, thus paving way for nutritional deficiency status to set in. Red Cell Distribution Width (RDW) is a hematological parameter which measures variation in the size of red blood cells (RBC's). It appears that changes in RBC's occur much before the appearance of severe clinical features corresponding to deficiency status which may be assessed using alterations in mean cell volume (MCV) and RDW. Aims: To assess RDW and other hematological parameters in patients with OSMF and to correlate with various stages of OSMF. Materials and Methods: Blood samples were taken from clinically confirmed 41 cases of OSMF and 30 cases of control group and were subjected for automated complete blood estimation. Statistical Analysis: T-test, one-way analysis of variance (ANOVA) test and Turkeys multiple posts hoc procedures. Results: RDW values were increased in almost all OSMF cases with statistically significant difference between cases and controls while other hematological parameters like haemoglobin (HB), MCV, mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) showed no statistically significant differences. These hematological values were independent of the stages of the disease and did not show any difference in various stages except the eosinophil count. Conclusion: The study reveals increased RDW values in all OSMF patients inspite of normal hemoglobin levels in most of them, indicating a pre-anemic state. Eosinophils also progressively increased with each stage of OSMF. [ABSTRACT FROM AUTHOR]
- Published
- 2014
30. Alveolar rhabdomyosarcoma of vulva
- Author
-
Puranik Rekha, Naik Sujatha, Kulkarni Shridhar, and Kulkarni M
- Subjects
Pathology ,RB1-214 ,Microbiology ,QR1-502 - Published
- 2010
31. Swelling on lower lip...not always a mucocele!!!
- Author
-
Gudi, Santosh S., Sikkerimath, B. C., Puranik, R. S., and Kasbe, Snehal S.
- Subjects
MOUTH tumors ,ACOUSTIC neuroma ,SALIVARY glands - Abstract
Schwannomas are well characterized uncommon neural neoplasms which may rarely present with variation in clinical manifestation. Oral Schwannomas clinically simulate other lesions like traumatic fibroma, pyogenic granuloma, mucocele and salivary gland lesions. The diagnosis of schwannoma is typically made at the time of surgery following biopsy and surgical resection is the mainstay of treatment with no chances of recurrence as they are well encapsulated. We present a case of schwannoma of lower lip occurring in a 21-year-old female patient. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
32. Recurrent oral ulceration.
- Author
-
Puranik SR, Puranik R, and Sattigeri A
- Published
- 2011
- Full Text
- View/download PDF
33. Localized gingival growths: do they belong to the common spectrum called frog?
- Author
-
Puranik R and Puranik SR
- Published
- 2011
- Full Text
- View/download PDF
34. Comparison of 6-lead smartphone ECG and 12-lead ECG in athletes and a genetic heart disease population.
- Author
-
Davis AJ, Orchard JW, McGhie D, Broadbridge D, Raju H, La Gerche A, Puranik R, Gray B, De Jongh J, Driscoll T, and Orchard JJ
- Abstract
Background: Smartphone electrocardiograms (iECGs) are an innovative method of capturing transient arrhythmias which are occasionally experienced by athletes. This study aimed to assess the accuracy of a 6-lead iECG compared with 12-lead ECG in athletes and those with known genetic heart disease (positive controls)., Research Design and Methods: Each participant had a resting 12-lead ECG (supine) and a 30 second 6-lead iECG (seated) taken within 2 hours. Manual measurements of heart rate, QTc and PR intervals, and QRS duration were completed using digital calipers. Bland-Altman analysis was used to assess the quantitative agreement of measurements., Results: The 6-lead readings for heart rate were faster than the 12-lead in athletes ( n = 233) and positive controls ( n = 49). All other measurements were shorter in the 6-lead. QTc mean difference was smaller in the positive controls (4.7 ± 26.0 ms) than in athletes (12.5 ± 25.0 ms). The largest difference was in PR intervals, both in athletes (12.8 ± 17.7 ms) and positive controls (7.6 ± 18.9 ms). QRS duration had the smallest mean difference (0.6 ± 9.0 ms in athletes, 1.0 ± 12.7 ms in positive controls)., Conclusions: The 6-lead readings had reasonable agreement with the 12-lead ECG. A 6-lead iECG is a reasonable option to opportunistically capture arrhythmias that may occur infrequently, but should not replace a 12-lead if available.
- Published
- 2024
- Full Text
- View/download PDF
35. Rationale and Design of the Australasian Registry of Screening ECGs in National Athletes Project.
- Author
-
Orchard JJ, La Gerche A, Puranik R, Raju H, Davis AJ, Eggleton S, Driscoll T, Lorimer M, Doughty RN, Hamilton B, Drezner JA, and Orchard JW
- Subjects
- Humans, Female, Male, Prospective Studies, Retrospective Studies, Australia epidemiology, Heart Diseases diagnosis, Heart Diseases epidemiology, Research Design, Adult, Longitudinal Studies, Registries, Electrocardiography, Athletes, Mass Screening methods, Death, Sudden, Cardiac epidemiology, Death, Sudden, Cardiac prevention & control
- Abstract
Background: Cardiac screening of elite athletes is widely recommended by Australasian sporting federations, but data are not structured to be shared. Data are lacking from underrepresented groups to inform ECG interpretation guidelines. The ARENA (Australasian Registry of Screening ECGs in National Athletes) project is a retrospective and prospective, multicenter, longitudinal, observational registry of athlete cardiac screening results and outcomes. The aim is to create a repository to improve our understanding of the diagnoses and outcomes of screening., Methods: Participating sports that conduct cardiac screening of athletes will contribute data. This includes an initial collection (retrospective data, waiver of consent) and future prospective data (opt-out consent). Data include sex, age, sport/event, screening date, ECG findings, cardiac test results, follow-up details, sport participation status, cardiac diagnoses, and major cardiovascular outcomes defined as sudden cardiac arrest/death, cardiac syncope or implanted cardioverter defibrillator shock, cardiac hospitalization, and arrhythmias requiring intervention. Comparisons will be made between diagnoses, outcomes, and ECG features and analyzed by sport and sex. The ARENA project was developed in collaboration with sporting bodies, team physicians, and players association representatives and endorsed by the Australasian College of Sport & Exercise Physicians and Sports Medicine Australia., Conclusions: The ARENA project will provide a long-term international data repository to improve our understanding of ECG interpretation, cardiac screening and diagnoses, and the prevalence of cardiovascular outcomes in screened athletes. A unique aim is to address evidence gaps in underrepresented athlete groups, specifically female athletes and Indigenous populations. Results will inform screening policies and guidelines.
- Published
- 2024
- Full Text
- View/download PDF
36. Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution.
- Author
-
Fairley JL, O'Rourke R, Puranik R, and Nikpour M
- Abstract
Cardiac magnetic resonance imaging (CMR) is the gold-standard non-invasive method of assessing cardiac structure and function, including tissue characterisation. In systemic sclerosis (SSc), heart involvement (SHI) is a leading cause of mortality yet remains poorly understood. SHI is underestimated by conventional echocardiography, and CMR provides an important opportunity to better identify and quantify subtle myocardial changes including oedema and fibrosis. This review summarises current CMR techniques, the role of CMR in SSc and SHI, and the opportunities to further our understanding of its pathogenesis and management., Competing Interests: Conflicts of interest MN has received honoraria or consultancies from Janssen, AstraZeneca, GlaxoSmithKlein, Boehringer-Ingelheim and Bristol-Myers Squibb. JF has received conference sponsorship from Pfizer and honoraria from Boehringer-Ingelheim., (© 2024 Jessica L Fairley, Rachael O’Rourke, Rajesh Puranik, Mandana Nikpour, published by De Gruyter on behalf of NCRC-DID.)
- Published
- 2024
- Full Text
- View/download PDF
37. Hibernoma: a case report of a rare cardiac tumour.
- Author
-
Cistulli D, Othman F, Karim R, and Puranik R
- Abstract
Background: A cardiac hibernoma is a rare phenomenon, with just a handful of reports in the literature. They are difficult to characterize with conventional imaging including echocardiography, computed tomography (CT), cardiac magnetic resonance (CMR), or positron emission tomography (PET). Their definitive diagnosis relies primarily on histopathology via either endovascular or surgical biopsy. Previous case reports have entailed surgical excision followed by histopathology; however, surgery may be unfavourable in some patients with increased perioperative risk., Case Summary: We present the case of a 57-year-old woman who was referred to our cardiology service with an interatrial lipomatous mass found incidentally on chest CT for assessment of rib fractures. She had 6 months of unexplained syncope, which was attributed to superior vena cava (SVC) compression demonstrated by chest CT. The mass had benign characteristics on echocardiography, CT, and CMR but was glucose-avid on PET, which indicated a possible malignancy such as liposarcoma. Her comorbid and very significant airways disease precluded her from surgical excision, so instead, endovascular biopsy was performed. Histopathology showed brown fat which was negative for mouse double minute 2 amplification on fluorescence in situ hybridisation testing; hence, a diagnosis was made of hibernoma, a rare benign tumour of brown fat. Given the benign diagnosis and her surgical risk with severe chronic obstructive pulmonary disease, a multidisciplinary recommendation was made favouring conservative management, with careful ongoing follow-up and the consideration of SVC stenting if symptoms progressed., Discussion: The definitive diagnosis of a cardiac hibernoma is complex and relies heavily on histopathology due to the contradictory findings on chest imaging. Careful consideration of management within a multidisciplinary team setting is essential to achieve a successful outcome., Competing Interests: Conflict of interest: None declared., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2023
- Full Text
- View/download PDF
38. A case series of patients with filamin-C truncating variants attending a specialized cardiac genetic clinic.
- Author
-
Hespe S, Isbister JC, Duflou J, Puranik R, Bagnall RD, Semsarian C, Gray B, and Ingles J
- Abstract
Background: FLNC encodes for filamin-C, a protein expressed in Z-discs of cardiac and skeletal muscle, involved in intracellular signalling and mechanical stabilization. Variants can cause diverse phenotypes with skeletal (myofibrillar or distal myopathy) and/or cardiac (hypertrophic, restrictive, and arrhythmogenic cardiomyopathies) manifestations. Truncating variants have recently been implicated in arrhythmogenic cardiomyopathy (ACM) without skeletal disease., Case Summary: Retrospective review of medical records, including cardiac investigations, was performed for families attending a specialized clinic with a FLNC truncating variant ( FLNC tv). Variants were classified according to accepted variant interpretation criteria. Of seven families identified, six had primary cardiac phenotypes with one nonsense and five frameshift variants (nonsense-mediated decay competent) identified. One family had no cardiac phenotype, with a pathogenic variant (p.Arg2467Alafs*62) identified as secondary genetic finding. Of the six with cardiac phenotypes, proband age at diagnosis ranged 27-35 years (four females). Five families experienced sudden cardiac death (SCD) of a young relative (age range: 30-43 years), and one patient listed for cardiac transplant. Left ventricular (LV) ejection fraction ranged from 13 to 46%, with LV fibrosis (late gadolinium enhancement) on cardiac imaging or on postmortem histology seen in three families. Two families had one genotype-positive/phenotype-negative relative., Discussion: The FLNC tv causes a left-sided ACM phenotype with a high risk of severe cardiac outcomes including end-stage heart failure and SCD. Incomplete penetrance is observed with implications for reporting secondary genetic findings., Competing Interests: Conflict of interest: None declared., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2023
- Full Text
- View/download PDF
39. Coronary microvascular dysfunction: A review of recent progress and clinical implications.
- Author
-
Rehan R, Yong A, Ng M, Weaver J, and Puranik R
- Abstract
The coronary microcirculation plays a cardinal role in regulating coronary blood flow to meet the changing metabolic demands of the myocardium. Coronary microvascular dysfunction (CMD) refers to structural and functional remodeling of the coronary microcirculation. CMD plays a role in the pathogenesis of obstructive and non-obstructive coronary syndromes as well as myocardial diseases, including heart failure with preserved ejection fraction (HFpEF). Despite recent diagnostic advancements, CMD is often under-appreciated in clinical practice, and may allow for the development of novel therapeutic targets. This review explores the diagnosis and pathogenic role of CMD across a range of cardiovascular diseases, its prognostic significance, and the current therapeutic landscape., Competing Interests: AY was received honoraria and research support from Abbott Vascular and Philips Healthcare. MN was received research support from Abbott Vascular. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Rehan, Yong, Ng, Weaver and Puranik.)
- Published
- 2023
- Full Text
- View/download PDF
40. Automatic segmentation of the great arteries for computational hemodynamic assessment.
- Author
-
Montalt-Tordera J, Pajaziti E, Jones R, Sauvage E, Puranik R, Singh AAV, Capelli C, Steeden J, Schievano S, and Muthurangu V
- Subjects
- Humans, Retrospective Studies, Predictive Value of Tests, Aorta diagnostic imaging, Hemodynamics, Magnetic Resonance Imaging
- Abstract
Background: Computational fluid dynamics (CFD) is increasingly used for the assessment of blood flow conditions in patients with congenital heart disease (CHD). This requires patient-specific anatomy, typically obtained from segmented 3D cardiovascular magnetic resonance (CMR) images. However, segmentation is time-consuming and requires expert input. This study aims to develop and validate a machine learning (ML) method for segmentation of the aorta and pulmonary arteries for CFD studies., Methods: 90 CHD patients were retrospectively selected for this study. 3D CMR images were manually segmented to obtain ground-truth (GT) background, aorta and pulmonary artery labels. These were used to train and optimize a U-Net model, using a 70-10-10 train-validation-test split. Segmentation performance was primarily evaluated using Dice score. CFD simulations were set up from GT and ML segmentations using a semi-automatic meshing and simulation pipeline. Mean pressure and velocity fields across 99 planes along the vessel centrelines were extracted, and a mean average percentage error (MAPE) was calculated for each vessel pair (ML vs GT). A second observer (SO) segmented the test dataset for assessment of inter-observer variability. Friedman tests were used to compare ML vs GT, SO vs GT and ML vs SO metrics, and pressure/velocity field errors., Results: The network's Dice score (ML vs GT) was 0.945 (interquartile range: 0.929-0.955) for the aorta and 0.885 (0.851-0.899) for the pulmonary arteries. Differences with the inter-observer Dice score (SO vs GT) and ML vs SO Dice scores were not statistically significant for either aorta or pulmonary arteries (p = 0.741, p = 0.061). The ML vs GT MAPEs for pressure and velocity in the aorta were 10.1% (8.5-15.7%) and 4.1% (3.1-6.9%), respectively, and for the pulmonary arteries 14.6% (11.5-23.2%) and 6.3% (4.3-7.9%), respectively. Inter-observer (SO vs GT) and ML vs SO pressure and velocity MAPEs were of a similar magnitude to ML vs GT (p > 0.2)., Conclusions: ML can successfully segment the great vessels for CFD, with errors similar to inter-observer variability. This fast, automatic method reduces the time and effort needed for CFD analysis, making it more attractive for routine clinical use., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
41. Longitudinal assessment of structural phenotype in Brugada syndrome using cardiac magnetic resonance imaging.
- Author
-
Isbister JC, Gray B, Offen S, Yeates L, Naoum C, Medi C, Raju H, Semsarian C, Puranik R, and Sy RW
- Abstract
Background: Despite historically being considered a channelopathy, subtle structural changes have been reported in Brugada syndrome (BrS) on histopathology and cardiac magnetic resonance (CMR) imaging. It is not known if these structural changes progress over time., Objective: The study sought to assess if structural changes in BrS evolve over time with serial CMR assessment and to investigate the utility of parametric mapping techniques to identify diffuse fibrosis in BrS., Methods: Patients with a diagnosis of BrS based on international guidelines and normal CMR at least 3 years prior to the study period were invited to undergo repeat CMR. CMR images were analyzed de novo and compared at baseline and follow-up., Results: Eighteen patients with BrS (72% men; mean age at follow-up 47.4 ± 8.9 years) underwent serial CMR with an average of 5.0 ± 1.7 years between scans. No patients had late gadolinium enhancement (LGE) on baseline CMR, but 4 (22%) developed LGE on follow-up, typically localized to the right ventricular (RV) side of the basal septum. RV end-systolic volume increased over time ( P = .04) and was associated with a trend toward reduction in RV ejection fraction ( P = .07). Four patients showed a reduction in RV ejection fraction >10%. There was no evidence of diffuse myocardial fibrosis observed on parametric mapping., Conclusions: Structural changes may evolve over time with development of focal fibrosis, evidenced by LGE on CMR in a significant proportion of patients with BrS. These findings have implications for our understanding of the pathological substrate in BrS and the longitudinal evaluation of patients with BrS., (© 2022 Heart Rhythm Society. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
42. Prevention of the spread of respiratory viruses such as SARS-CoV-2 can also prevent cardiovascular deaths.
- Author
-
Orchard JW, Orchard JJ, Workman C, and Puranik R
- Subjects
- Humans, SARS-CoV-2, COVID-19 prevention & control, Viruses
- Published
- 2022
- Full Text
- View/download PDF
43. A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia.
- Author
-
Sinclair JE, Mayfield HJ, Short KR, Brown SJ, Puranik R, Mengersen K, Litt JCB, and Lau CL
- Abstract
The Pfizer COVID-19 vaccine is associated with increased myocarditis incidence. Constantly evolving evidence regarding incidence and case fatality of COVID-19 and myocarditis related to infection or vaccination, creates challenges for risk-benefit analysis of vaccination. Challenges are complicated further by emerging evidence of waning vaccine effectiveness, and variable effectiveness against variants. Here, we build on previous work on the COVID-19 Risk Calculator (CoRiCal) by integrating Australian and international data to inform a Bayesian network that calculates probabilities of outcomes for the delta variant under different scenarios of Pfizer COVID-19 vaccine coverage, age groups (≥12 years), sex, community transmission intensity and vaccine effectiveness. The model estimates that in a population where 5% were unvaccinated, 5% had one dose, 60% had two doses and 30% had three doses, there was a substantially greater probability of developing (239-5847 times) and dying (1430-384,684 times) from COVID-19-related than vaccine-associated myocarditis (depending on age and sex). For one million people with this vaccine coverage, where transmission intensity was equivalent to 10% chance of infection over 2 months, 68,813 symptomatic COVID-19 cases and 981 deaths would be prevented, with 42 and 16 expected cases of vaccine-associated myocarditis in males and females, respectively. These results justify vaccination in all age groups as vaccine-associated myocarditis is generally mild in the young, and there is unequivocal evidence for reduced mortality from COVID-19 in older individuals. The model may be updated to include emerging best evidence, data pertinent to different countries or vaccines and other outcomes such as long COVID., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
44. A Rare Cause of Ankle Pain - Chondrosarcoma of the Talus: A Case Report and Literature Review.
- Author
-
Tupe R, Panchwagh Y, Bartakke G, Puranik R, and Waghchoure C
- Abstract
Introduction: Chondrosarcoma of the talus is one of the rare causes of ankle pain. Often this pain is neglected by the patients. Hence, the presentation is late. A rare occurrence, lack of clinical familiarity, and resemblance to enchondroma make the diagnosis of chondrosarcoma difficult., Case Report: We present a case of chondrosarcoma of talus in a 42-year-old female, which is an uncommon site of occurrence. In the presence of non-classical radiologic and histologic findings, the patient was treated with below-knee amputation. At present, the patient is disease-free and walking with a prosthesis., Conclusion: Talus is an infrequent site for chondrosarcoma. When affected, it presents as vague ankle pain. A patient can be underdiagnosed as there are no clear radiological and histological guidelines to differentiate between benign and low-grade cartilaginous tumors such as enchondroma and low-grade chondrosarcoma. Histologically proven benign lesions must be followed for a long time in suspicion of malignancy. The treatment of chondrosarcoma of the talus can vary from local wide excision to below-knee amputation, depending on the grade of malignancy., Competing Interests: Conflict of Interest: Nil, (Copyright: © Indian Orthopaedic Research Group.)
- Published
- 2022
- Full Text
- View/download PDF
45. High Rates of Ultraviolet-Signature Mutations in Squamous Cell Carcinomas of the Parotid Gland and Prognostic Implications.
- Author
-
Fishbach S, Steinhardt G, Zhen CJ, Puranik R, Segal JP, and Cipriani NA
- Subjects
- Humans, Mutation, Parotid Gland pathology, Prognosis, Carcinoma, Squamous Cell pathology, Parotid Neoplasms genetics, Skin Neoplasms pathology
- Abstract
In the absence of clear pathologic differences, clinical history may differentiate potential primary parotid squamous cell carcinomas (SCC) from metastases. The presence of an ultraviolet (UV) signature can distinguish between tumors of cutaneous and non-cutaneous origin. This study aimed to investigate rates of UV signature mutations in squamous cell carcinomas of the parotid gland as well as differences in clinical features between tumors of cutaneous and non-cutaneous origin. Clinical and pathologic data were collected from 71 patients with SCC involving the parotid gland, of which 48 had cutaneous, 10 had mucosal, and 13 had no history of SCC. In 34 available cases, genomic DNA was isolated from formalin-fixed paraffin-embedded tissue specimens and sequenced using a targeted hybrid capture 1213 gene panel. Tumor mutational burden and COSMIC (Catalogue of Somatic Mutations in Cancer) mutational signatures were calculated. Most (74%) were UV-positive. Patients with UV-positive tumors were significantly older, white, and had higher rates of sun exposure. Patients with UV-negative tumors had a significantly higher mortality rate and shorter time to death: 6 (67%) died of disease with a median time to death of 9 months compared to 5 (20%) UV-positive patients who died of disease with a median time to death of 32 months. Pathologic features did not significantly vary by clinical history or UV status. The presence of a UV-signature combined with clinical history can be used to determine the primary source of SCC involving the parotid gland. UV-positivity may reflect a less aggressive disease course in an older population., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
46. Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design.
- Author
-
Tran DL, Gibson H, Maiorana AJ, Verrall CE, Baker DW, Clode M, Lubans DR, Zannino D, Bullock A, Ferrie S, Briody J, Simm P, Wijesekera V, D'Almeida M, Gosbell SE, Davis GM, Weintraub R, Keech AC, Puranik R, Ugander M, Justo R, Zentner D, Majumdar A, Grigg L, Coombes JS, d'Udekem Y, Morris NR, Ayer J, Celermajer DS, and Cordina R
- Abstract
Background: Despite developments in surgical techniques and medical care, people with a Fontan circulation still experience long-term complications; non-invasive therapies to optimize the circulation have not been established. Exercise intolerance affects the majority of the population and is associated with worse prognosis. Historically, people living with a Fontan circulation were advised to avoid physical activity, but a small number of heterogenous, predominantly uncontrolled studies have shown that exercise training is safe-and for unique reasons, may even be of heightened importance in the setting of Fontan physiology. The mechanisms underlying improvements in aerobic exercise capacity and the effects of exercise training on circulatory and end-organ function remain incompletely understood. Furthermore, the optimal methods of exercise prescription are poorly characterized. This highlights the need for large, well-designed, multi-center, randomized, controlled trials. Aims and Methods: The Fontan Fitness Intervention Trial (F-FIT)-a phase III clinical trial-aims to optimize exercise prescription and delivery in people with a Fontan circulation. In this multi-center, randomized, controlled study, eligible Fontan participants will be randomized to either a 4-month supervised aerobic and resistance exercise training program of moderate-to-vigorous intensity followed by an 8-month maintenance phase; or usual care (control group). Adolescent and adult (≥16 years) Fontan participants will be randomized to either traditional face-to-face exercise training, telehealth exercise training, or usual care in a three-arm trial with an allocation of 2:2:1 (traditional:telehealth:control). Children (<16 years) will be randomized to either a physical activity and exercise program of moderate-to-vigorous intensity or usual care in a two-arm trial with a 1:1 allocation. The primary outcome is a change in aerobic exercise capacity (peak oxygen uptake) at 4-months. Secondary outcomes include safety, and changes in cardiopulmonary exercise testing measures, peripheral venous pressure, respiratory muscle and lung function, body composition, liver stiffness, neuropsychological and neurocognitive function, physical activity levels, dietary and nutritional status, vascular function, neurohormonal activation, metabolites, cardiac function, quality of life, musculoskeletal fitness, and health care utilization. Outcome measures will be assessed at baseline, 4-months, and 12-months. This manuscript will describe the pathophysiology of exercise intolerance in the Fontan circulation and the rationale and protocol for the F-FIT., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Tran, Gibson, Maiorana, Verrall, Baker, Clode, Lubans, Zannino, Bullock, Ferrie, Briody, Simm, Wijesekera, D'Almeida, Gosbell, Davis, Weintraub, Keech, Puranik, Ugander, Justo, Zentner, Majumdar, Grigg, Coombes, d'Udekem, Morris, Ayer, Celermajer and Cordina.)
- Published
- 2022
- Full Text
- View/download PDF
47. Right ventricular volume and its relationship to functional tricuspid regurgitation.
- Author
-
Offen SM, Baker D, Puranik R, and Celermajer DS
- Abstract
Background: Significant right ventricular (RV) dilatation has long been considered integral to the pathogenesis of functional tricuspid regurgitation (FTR)., Objectives: To explore the relationship of RV dilatation and FTR in patients with 'pure' RV volume overload., Methods: Patients (>17yrs) with RV dilatation due to pre-tricuspid shunts (atrial septal defect; ASD and/or partial anomalous pulmonary venous drainage; PAPVD) referred to our service (2000-2019) were retrospectively identified. Those with pulmonary hypertension, primum ASD or left-heart disease were excluded. Using standard cardiac MRI protocols, RV, right atrial and TV parameters were measured and compared., Results: Of 52 consecutively eligible patients (42 ± 15yrs, 25 males), 25 had ASDs, 13 had PAPVD and 14 had both conditions. All were in sinus rhythm and none had pulmonary regurgitation. Left and right ventricular ejection fractions were normal (LVEF 63 ± 8%, RVEF 56 ± 8%). Indexed RV end-diastolic volumes (RVEDVi) were moderately increased (males 148 ± 33 mL/m
2 and females 141 ± 42 mL/m2 , range 95-267 mL/m2 ). Despite substantial RV volume overload, no patients had severe tricuspid regurgitation (TR). Only two had > mild TR. There was a weak correlation between tricuspid annular diameter and both degree of RV dilatation (r = 0.37; p = 0.01) and degree of TR (r = 0.38; p = 0.006). There was a similarly poor correlation between right atrial dimensions and the degree of TR (r = 0.34; p = 0.02)., Conclusion: When RV dilatation is simply due to volume overload, we find that significant TR is extremely rare. This gives an important and novel insight; that RV dilatation per se does not result in FTR., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 The Authors.)- Published
- 2021
- Full Text
- View/download PDF
48. 'Stay home when sick' advice: implications for sport and exercise.
- Author
-
Orchard JW, Orchard JJ, and Puranik R
- Abstract
The coronavirus pandemic has given everyone in society an education on the harms of spread of respiratory illness. Young healthy athletes are far less likely to suffer severe adverse consequences of viral illnesses than the elderly and frail, but they are not completely immune. Chronic fatigue (overtraining) is an uncommon outcome and myocarditis a rare one, but they both warrant due consideration. It is, therefore, a sensible individual strategy to 'stay home when sick' if only for these risks. Traditionally though, athletes have tended to push through (train and play when ill) because of competing concerns, such as key events/matches and 'not wanting to let teammates down'. Data from both low COVID-19 and high COVID-19 countries show that the number of cardiovascular deaths in a society correlates with the number of respiratory deaths at the same time, further linking respiratory viruses to cardiovascular deaths. We are now more aware of public health obligations to prevent the spread of respiratory illnesses, in particular to protect the more vulnerable members the community. This hopefully will correspond with a change in the culture of sport to one where it is considered 'the right thing to do', to 'stay home when sick'., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
49. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.
- Author
-
Law CC, Puranik R, Fan J, Fei J, Hambly BD, and Bao S
- Abstract
Atherosclerosis, which is a primary cause of cardiovascular disease (CVD) deaths around the world, is a chronic inflammatory disease that is characterised by the accumulation of lipid plaques in the arterial wall, triggering inflammation that is regulated by cytokines/chemokines that mediate innate and adaptive immunity. This review focuses on IL-32, -34 and -37 in the stable vs. unstable plaques from atherosclerotic patients. Dysregulation of the novel cytokines IL-32, -34 and -37 has been discovered in atherosclerotic plaques. IL-32 and -34 are pro-atherogenic and associated with an unstable plaque phenotype; whereas IL-37 is anti-atherogenic and maintains plaque stability. It is speculated that these cytokines may contribute to the explanation for the increased occurrence of atherosclerotic plaque rupture seen in patients with COVID-19 infection. Understanding the roles of these cytokines in atherogenesis may provide future therapeutic perspectives, both in the management of unstable plaque and acute coronary syndrome, and may contribute to our understanding of the COVID-19 cytokine storm., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Law, Puranik, Fan, Fei, Hambly and Bao.)
- Published
- 2021
- Full Text
- View/download PDF
50. Post-mortem cardiac magnetic resonance parameters in normal and diseased conditions.
- Author
-
Femia G, Langlois N, Raleigh J, Perumal SR, Semsarian C, and Puranik R
- Abstract
Background: Post-mortem cardiac magnetic resonance (CMR) is a non-invasive alternative to conventional autopsy. At present, diagnostic guidelines for cardiovascular conditions such as hypertrophic cardiomyopathy have not been established. We correlated post-mortem CMR images to definite conventional autopsy findings and hypothesed that elevated T2-weighted signal intensity and RV to LV area ratios can identify myocardial infarction and pulmonary emboli respectively., Methods: For this unblinded pilot sub-study, we selected cases from the original blinded study that compared post-mortem imaging to conventional autopsy in patients referred for coronial investigation between October 2014 to November 2016. Three groups of scans were selected based on the cause of death identified by conventional autopsy: non-cardiovascular causes of death with no structural cardiac abnormality i.e., control cases, acute/subacute myocardial infarction and pulmonary emboli. Left ventricular (LV) wall thickness, LV myocardial signal intensity and ventricular cavity areas were measured., Results: Fifty-six scans were selected [39 (69.6%) males]: 37 (66.1%) controls, eight (14.3%) acute/subacute myocardial infarction and eleven (19.6%) pulmonary emboli. The median age was 61 years [Interquartile range (IQR) 50-73] and the median time from death to imaging and autopsy was 2 days (IQR 2-3) and 3 days (IQR 3-4). The septal and lateral walls were thicker {15 mm [13-17] and 15 mm [14-18]} on post-mortem CMR than published ante-mortem measurements. Areas of acute/subacute myocardial infarction had significantly higher T2-weighted signal intensity (normalised to skeletal muscle) compared to normal myocardium in those who died from other causes {2.5 [2.3-3.0.] vs. 1.9 [1.8-2.3]; P<0.001}. In cases with pulmonary emboli, there was definite RV enlargement with a larger indexed RV to LV area ratio compared to those who died from other causes {2.9 [2.5-3.0] vs. 1.8 [1.5-2.0]; P<0.001}., Conclusions: We present potential post-mortem CMR parameters to identify important cardiovascular abnormalities that may be beneficial when conventional autopsy cannot be performed. In patients without cardiovascular disease, LV wall thickness was found to be unreliable in diagnosing hypertrophic cardiomyopathy without histological and/or genetic testing. Elevated T2 signal intensity and RV to LV area ratios may be useful markers for acute/subacute myocardial infarction and pulmonary emboli. Larger studies will be necessary to define cut-offs., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at: http://dx.doi.org/10.21037/cdt-20-948). The authors have no conflicts of interest to declare., (2021 Cardiovascular Diagnosis and Therapy. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.